▲ +12.96% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Soliton in the last 3 months. The average price target is $20.33, with a high forecast of $25.00 and a low forecast of $16.00. The average price target represents a 12.96% upside from the last price of $18.00.
The current consensus among 2 contributing investment analysts is to buy stock in Soliton.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas.